1. Home
  2. EARN vs AMRN Comparison

EARN vs AMRN Comparison

Compare EARN & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EARN

Ellington Residential Mortgage REIT of Beneficial Interest

HOLD

Current Price

$4.20

Market Cap

169.8M

Sector

Real Estate

ML Signal

HOLD

Logo Amarin Corporation plc

AMRN

Amarin Corporation plc

HOLD

Current Price

$13.56

Market Cap

287.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EARN
AMRN
Founded
2012
1989
Country
United States
Ireland
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
169.8M
287.9M
IPO Year
2012
1998

Fundamental Metrics

Financial Performance
Metric
EARN
AMRN
Price
$4.20
$13.56
Analyst Decision
Buy
Strong Sell
Analyst Count
2
1
Target Price
$5.38
★ $12.00
AVG Volume (30 Days)
★ 330.9K
52.0K
Earning Date
06-16-2026
04-29-2026
Dividend Yield
★ 20.51%
N/A
EPS Growth
N/A
★ 55.00
EPS
N/A
★ N/A
Revenue
N/A
★ $181,104,000.00
Revenue This Year
$7.69
N/A
Revenue Next Year
$19.57
$1.26
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 39.22
52 Week Low
$4.10
$12.96
52 Week High
$5.73
$20.90

Technical Indicators

Market Signals
Indicator
EARN
AMRN
Relative Strength Index (RSI) 42.08 42.48
Support Level N/A $13.32
Resistance Level $4.49 $14.50
Average True Range (ATR) 0.06 0.37
MACD -0.00 -0.02
Stochastic Oscillator 42.86 32.37

Price Performance

Historical Comparison
EARN
AMRN

About EARN Ellington Residential Mortgage REIT of Beneficial Interest

Ellington Credit Co The Fund is focused on acquiring and actively managing a portfolio of corporate CLOs, mainly mezzanine debt and equity tranches, which are typically collateralized by portfolios consisting mainly of below-investment-grade senior secured loans with a large number of discrete underlying borrowers across various industry sectors. Additionally, the Fund may also invest in CLO loan accumulation facilities, which are entities that acquire corporate loans and other similar corporate credit-related assets in anticipation of ultimately collateralizing a CLO transaction. The company's primary investment objectives are to generate attractive current income and risk-adjusted total returns for shareholders.

About AMRN Amarin Corporation plc

Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses on treatments to stop cardiovascular disease causing death, by providing patients, doctors and investors with reliable cardiovascular treatment options. Geographically, the company derives maximum revenue from United States.

Share on Social Networks: